1 |
Frankowski M, Świerkot J, Gomułkiewicz M, Korman L, Skoczyńska M, Starba A. Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis. Rheumatol Int 2021. [PMID: 34870735 DOI: 10.1007/s00296-021-05059-z] [Reference Citation Analysis]
|
2 |
Azzam A, Jiyad Z, O'Beirne J. Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta-analysis. Australas J Dermatol 2021;62:130-40. [PMID: 33769558 DOI: 10.1111/ajd.13546] [Reference Citation Analysis]
|
3 |
Feuchtenberger M, Kraus L, Nigg A, Schulze-Koops H, Schäfer A. Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study). Rheumatol Int 2021;41:1079-87. [PMID: 33608744 DOI: 10.1007/s00296-021-04804-8] [Reference Citation Analysis]
|
4 |
Floris A, Perra D, Cangemi I, Congia M, Chessa E, Angioni MM, Mangoni AA, Erre GL, Mathieu A, Piga M, Cauli A. Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study. Medicine (Baltimore) 2021;100:e25481. [PMID: 33907096 DOI: 10.1097/MD.0000000000025481] [Reference Citation Analysis]
|
5 |
Erre GL, Castagna F, Sauchella A, Meloni P, Mangoni AA, Farina G, Woodman R, Dore MP, Vidili G. Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case-control study. Ther Adv Musculoskelet Dis 2021;13:1759720X211042739. [PMID: 34819999 DOI: 10.1177/1759720X211042739] [Reference Citation Analysis]
|
6 |
Huang XJ, Wang J, Muhammad A, Tong HY, Wang DG, Li J, Ihsan A, Yang GZ. Systems pharmacology-based dissection of mechanisms of Tibetan medicinal compound Ruteng as an effective treatment for collagen-induced arthritis rats. J Ethnopharmacol 2021;272:113953. [PMID: 33610711 DOI: 10.1016/j.jep.2021.113953] [Reference Citation Analysis]
|